Cargando…
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Despite considerable epidemiological evidence indicating comorbidity between metabolic disorders, such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease, and inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis, as well as common pathophysiological featu...
Autor principal: | Hyun, Chang-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430512/ https://www.ncbi.nlm.nih.gov/pubmed/34502047 http://dx.doi.org/10.3390/ijms22179139 |
Ejemplares similares
-
Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
por: Lee, Jessica Y., et al.
Publicado: (2018) -
Inflammatory bowel disease in Korea: epidemiology and pathophysiology
por: Lee, Jung Won, et al.
Publicado: (2022) -
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
por: Abdulla, Maheeba, et al.
Publicado: (2022) -
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
por: Saez, Angela, et al.
Publicado: (2023) -
COVID-19 and inflammatory bowel disease: A pathophysiological assessment
por: Yang, Chunxiu, et al.
Publicado: (2021)